BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia

The Clinician and Clalit Health Services partner to drive value-based care and digital care pathway implementation in Israel

The Clinician, a global digital health innovator, has partnered with one of the largest HMOs in the world and Israel's largest healthcare o...

July 29, 2022 | News

Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney

The consortium partnership strives to advance a new vaccine concept that confers highly cross-reactive protection against numerous SARS-CoV-2 variants...

July 27, 2022 | News

Ozgene and Gen-H partner on Ozgene’s new OzBIG targeted humanization capability

Ozgene and Gen-H are pleased to announce our working partnership supporting Ozgene’s new OzBIG capability. Ozgene Pty Ltd is a privately held CRO bas...

July 25, 2022 | News

uLab™ clear aligner platform is now available in Australia and New Zealand

"Our expansion to the APAC region, starting with Australia and New Zealand, shows our commitment to provide orthodontists streamlined digita...

July 22, 2022 | News

Oncoshot Enters Collaboration Agreement With Omico

Oncoshot has just entered into a collaboration agreement with Omico, the Australian Genomic Cancer Medicine Centre. The respective parties were represented...

July 20, 2022 | News

Urgent support needed following the pandemic's effect on cancer screening services

Dry July Foundation is urging Australians to dig even deeper this Dry July to help people affected by cancer. So many Australians could not access vital li...

July 15, 2022 | News

ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment

TLX250-CDx, which has received "Breakthrough Designation" from the U.S. Food and Drug Administration (FDA)1, is being developed as an imaging agent for use...

July 11, 2022 | News

Australian developed VIRALEZE™ nasal spray relaunched by LloydsPharmacy in the UK

Extensive antiviral testing undertaken at the globally renowned Scripps Research Institute in the United States show that VIRALEZE&trad...

July 01, 2022 | News

Australia’s PrOSPeCT Project Is Sequencing Thousands of Cancer Patients

This March, Australia launched the Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT), which will sequence the genomes of more t...

June 23, 2022 | News

Telix and Invicro Advance AI Partnership

TelixAITM seeks to increase the efficiency and reproducibility of clinicians' imaging assessments using advanced analysis capabilities with an initial...

June 15, 2022 | News

Jubilant Radiopharma Joins Illuccix® Pharmacy Partner Network

The expansion of the distribution network facilitates broader patient access to Illuccix across the country, expanding availability into new regional marke...

June 14, 2022 | News

RAD adds brain tumor technology to portfolio

Sublicensing of promising imaging & therapeutic radiopharmaceutical from leading US university, Case Western Reserve University (CWRU),&nbs...

June 13, 2022 | News

Telix and RefleXion Expand Partnership for Prostate Cancer Treatment

BgRT is the first and only cancer treatment designed to integrate PET technology as part of external-beam radiotherapy delivery. It uses PET tracers a...

June 13, 2022 | News

US FDA Clears IND for Cynata's Phase 2 Clinical Trial of CYP-001 in GvHD

Key Highlights: US FDA has cleared Cynata's IND application for a Phase 2 clinical trial of CYP-001 in patients with aGvHD – a major mil...

May 27, 2022 | News

Stay Connected